Fig. 3: Neutralization activity of therapeutic monoclonal antibodies against BQ.1.1, BA.2.75.2, and BA.4.6. | Nature Communications

Fig. 3: Neutralization activity of therapeutic monoclonal antibodies against BQ.1.1, BA.2.75.2, and BA.4.6.

From: Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Fig. 3

a. Neutralization curves of monoclonal antibodies. Dose–response analysis of the neutralization by the indicated antibodies or their clinical combinations. Evusheld: Cilgavimab and Tixagevimab. Ronapreve: Casirivimab and Imdevimab. Data are mean ± s.d. of n = 2 independent experiments. b IC50 values in ng/ mL for each antibody against the indicated viral strains. *ED50 against BA.2 and BA.5 are from49. Source data are provided as a Source Data file.

Back to article page